2016
DOI: 10.1016/j.exer.2015.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Next-generation sequencing of ABCA4: High frequency of complex alleles and novel mutations in patients with retinal dystrophies from Central Europe

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
23
0
2

Year Published

2016
2016
2022
2022

Publication Types

Select...
8
1

Relationship

2
7

Authors

Journals

citations
Cited by 29 publications
(32 citation statements)
references
References 41 publications
1
23
0
2
Order By: Relevance
“…The Hungarian population was found to display a frequency of 28% among STGD patients [27]. Finally, Scieżyńska et al tested 93 unrelated Polish STGD and CRD patients and detected this allele in 33 individuals [16]. The population frequency was estimated as 0.42%.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The Hungarian population was found to display a frequency of 28% among STGD patients [27]. Finally, Scieżyńska et al tested 93 unrelated Polish STGD and CRD patients and detected this allele in 33 individuals [16]. The population frequency was estimated as 0.42%.…”
Section: Discussionmentioning
confidence: 99%
“…Variants c.[1622T>C;3113C>T], p.[Leu541Pro;Ala1038Val] found in cis were previously described to be present in 33% of Polish patients. Population frequency was estimated to be 0.42% [16]. However, the broader context of ABCA4 mutations in Poland, especially in the case of retinitis pigmentosa patients, has never been tested.…”
Section: Introductionmentioning
confidence: 99%
“…The sole application of microarray was enough to solve 76 cases, which were not further investigated with Sanger technique. Indeed, this may have led to an underestimation of the prevalence of novel additional mutations and/or complex alleles in this cohort [28,58]. The relatively high number of unsolved cases may be related to a combination of different factors: (1) The clinical overlap of distinct genetic entities could have led to uncertainties in patients’ selection.…”
Section: Discussionmentioning
confidence: 99%
“…More recently, exons and splice sites have been sequenced using an amplicon tagging protocol (Zernant et al 2011;Sciezynska et al 2016), array-based hybridization (Schulz et al 2017), targeted gene-panel sequencing (Consugar et al 2015) or whole exome sequencing (Ortube et al 2014;Zhou et al 2014;Bryant et al 2018). Sequence analysis of the entire 128-kb gene and up-and downstream DNA segments was performed using next-generation sequencing platforms after enrichment of ABCA4 sequences using Raindance microdroplet-PCR target enrichment or Illumina TruSeq Custom Amplicon target enrichment (Zernant et al 2014), Haloplex-based sequence enrichment Sangermano et al 2019), or WGS (Carss et al 2017;Sangermano et al 2019).…”
Section: Introductionmentioning
confidence: 99%